MHRA – Page 188 – Pharma.Tips

Ccit Failure after packaging change: packaging integrity and CCIT justification

Ccit Failures Following a Packaging Change: Understanding Integrity and Justification In the pharmaceutical manufacturing industry, the stability and quality of dosage forms are paramount. A CCIT (Container Closure Integrity Testing)…

E&L Failure in dental gel manufacturing: GMP investigation steps with CAPA

GMP Investigation Steps for E&L Failure in Dental Gel Manufacturing In the pharmaceutical manufacturing landscape, especially within dental dosage forms, defects related to extractables and leachables (E&L) can pose significant…

Tube Leakage Complaint during method transfer: QMS trending and complaint handling expectations

Addressing Tube Leakage Complaints During Method Transfers: Best Practices for Quality Management Systems Complaints regarding tube leakage during method transfers can significantly disrupt pharmaceutical manufacturing processes, especially for dosage forms…

Em Excursion after packaging change: sampling, filtration, and EM controls

Deviations Related to Em Excursion Following Packaging Changes: An In-depth Investigation Guide In the pharmaceutical industry, adherence to strict quality standards is paramount. An excursion in microbial contamination levels, particularly…

Pet Failure during inspection readiness: QMS trending and complaint handling expectations

Understanding Pet Failure During Inspection Readiness: Insights into QMS Trending and Complaint Management In the high-stakes environment of pharmaceutical manufacturing, being prepared for inspections is paramount. A common issue that…

Fill Weight Variability after supplier change: QMS trending and complaint handling expectations

Exploring Fill Weight Variability Following a Supplier Change: A Comprehensive Investigation Guide In pharmaceutical manufacturing, maintaining product quality is essential, and any deviations can significantly impact regulatory compliance and patient…

Suppository Deformation during bulk hold: CAPA with effectiveness checks for auditors

Addressing Suppository Deformation Issues During Bulk Hold: A Comprehensive CAPA Approach In the realm of pharmaceutical manufacturing, maintaining the integrity of product forms is vital. One such challenge arises with…

Particulate Matter Oos during method transfer: packaging integrity and CCIT justification

Investigation of Particulate Matter OOS During Method Transfer: Assessing Packaging Integrity and CCIT Justifications Issues related to particulate matter Out of Specification (OOS) results during method transfers can pose significant…

Pet Failure at accelerated stability: CAPA with effectiveness checks for auditors

Addressing Pet Failures in Accelerated Stability: An Investigation Guide for Pharma Professionals Pet failures during accelerated stability testing represent a significant challenge within pharmaceutical manufacturing, particularly for dosage forms such…

Tag: MHRA